Board meeting on November 3 to consider Q2 and H1 FY27 financial results

Profit growth above 25%EBITDA margin compressionNegative operating cash flowResults View source PDF Explain this filing

ZYDUSWELL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.0%Reaction day

₹515.00

prior close

₹512.85

announcement price

After-mkt

timing

Nifty Smallcap 250market+0.1%-0.1% vs market

Packaged Foods peers, median of 35sector-0.6%+0.6% vs sector

On the reaction day the stock moved 0.1 pts less than Nifty Smallcap 250 and 0.6 pts more than its Packaged Foods peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.8

10m

-0.7

15m

-0.9

30m

-0.7

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.0+0.1-0.1-0.6+0.6

Next day

+0.2-1.1+1.3-1.5+1.7

-4.6-3.3-1.2-3.7-0.8

-7.7-4.4-3.3-5.1-2.5

-8.0-7.0-0.9-6.4-1.5

-9.1-6.0-3.1-5.7-3.4

-9.7-3.6-6.1-6.2-3.5

15d

—————

UpDownMarket · Nifty Smallcap 250Sector · Packaged Foods peers, median of 35Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The Board of Directors of Zydus Wellness will meet on Tuesday, November 3, 2026 to consider and approve the unaudited financial results for the quarter and half year ended September 30, 2026. This covers Q2 and the first half of FY27. The company has informed both BSE (code 531335) and NSE (code ZYDUSWELL). The insider trading window stays closed until November 5, 2026 and reopens on November 6, 2026 for all directors and designated persons.

Likely market impact

Routine pre-results notice. Q2 and H1 FY27 numbers due on November 3 could move the stock based on revenue growth, margins or guidance.

By the numbersStandalone · Q2 FY27 vs Q2 FY26

	Q2 FY27	Q2 FY26	Change
Revenue	₹166.8 Cr	₹156.0 Cr	+6.9%
Operating profit	₹7.40 Cr	₹19.20 Cr	−61.5%
Profit after tax	₹11.60 Cr	₹7.60 Cr	+52.6%
EBITDA margin	10.3%	11.8%	−1.5 pp

From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.